The landscape of HIV prevention has undergone a profound transformation with significant advancements in medical interventions and a deeper understanding of how the virus spreads. These developments ...
Jared Baeten, MD, PhD, discusses the significance of the PURPOSE 1 trial results, which found that lenacapavir for pre-exposure prophylaxis resulted in no new infections of HIV. How significant is it ...
Implementation barriers remain largely programmatic, requiring integrated HIV testing, adherence support, STI services, and ...
Assam has the highest number of people living with HIV in Northeast India, with over thirty three thousand cases and a ...
MATRIX: A USAID Project to Advance the Research and Development of Innovative HIV Prevention Products for WomenDec 7 2023 A fast-dissolving vaginal insert that women would use at or around the time of ...
The aim of this paper is to advance rigorous Internet-based HIV/STD Prevention quantitative research by providing guidance to fellow researchers, faculty supervising graduates, human subjects' ...
PITTSBURGH – November 2, 2023 – A vaginal film designed to slowly dissolve over the course of 30 days is being put to the test for the first time in a study launched this week that aims to determine ...
Gauteng is set to roll out Lenacapavir, a new long-acting HIV prevention injection, targeting over 56,000 individuals at high risk of HIV infection.
Lenacapavir is a gamechanger in the field of global health, signifying a shift from HIV prevention that requires a daily routine to a long-acting and highly effective form of protection. Lenacapavir ...
The city supports the HIV nonprofits' goals but is itself grappling with budget constraints spurred by the Trump ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results